4th Annual Pharma R&D Asia Congress

In keeping with Oxford Global’s highly successful like sciences series, an expert panel of 40 speakers will present a full conference programme covering the topics outlined below.

Day 1 – Innovation Strategies to Advance R&D in Asia

• R&D collaborations between East & West
• Guaranteeing successful outsourcing partners
• Successful business models in Pharma R&D
• Multi-national pharma companies in emerging markets
• Developing a global regulatory strategy

Day 2 – Drug Development Activities in Asia

• Translational research strategies: discovery to development
• Regulatory considerations for multiregional drug approval
• Novel methods to accelerate drug development pipeline
• Drug development in oncology and other therapeutic areas
• Mergers & acquisitions to improve productivity

Co-located 3^rd Annual Clinical Trials and Outsourcing Asia Congress

Day 1 Stream 1 – Clinical Development Activities & Clinical Research Outsourcing Strategies

• Regional clinical development in Asia and Asia Pacific regions
• Ensuring clinical safety: toxicity predictions, PK/PD modelling & translation modelling
• Clinical development activities in oncology and other therapeutic areas
• Selecting the correct Pharma – CRO partnership for maximum success
• Clinical outsourcing strategies in Asia and Asia Pacific regions
• Global vs local: clinical development, clinical trials & CRO selection

Day 1 Stream 2 – Biomarkers, Companion Diagnostics & Personalised Medicine

• Imaging biomarkers: bridging preclinical and clinical research
• Translation of biomarkers in clinical development & clinical trials
• Companion diagnostics: clinical development & partnering strategies
• Personalised medicine in oncology clinical development
• Implementing biomarkers in early phase clinical trials

Day 2 Stream 1 – Clinical Trials Management Strategies in Asia and Asia Pacific Regions

• Implementing successful patient recruitment and retention strategies
• Country and site selection for global clinical trials
• Overcoming regulatory hurdles in Asia and Asia Pacific regions
• Managing clinical trials in oncology and other therapeutic areas
• Ensuring pharmacovigilance and patient safety in clinical trials in Asia
• Clinical supply chain management to maximise efficiency

2014 speakers include:

• Shailendra Bajpai
  Regional Medical Director, Sanofi, Singapore
• Jun Bao
  Senior Vice President, Shenogen Pharma Group, China
• Matthias Boedding
  Global Safety Leader, Global Pharmacovigilance – Risk Management, Global R&D Center Beijing, Bayer Healthcare, China
• Nathan Chen
  Senior Director, Asia Clinical Development Head, Pfizer, China
• Robert Chen
  Vice President, Global Strategy & Partnering, Genor BioPharma, China
• Rebecca Dai
  Head GCP&SM, Global Clinical Development, Bayer Healthcare, China
• Yuan-Hua Ding
  Senior Director, Head of External R&D Innovation – Asia/Pacific, Worldwide R&D, USA
• Victoria Elegant
  Vice-President, Medical, Clinical & Regulatory Affairs, Asia-Pacific, Baxter Healthcare, China
• Carl Frith
  CEO, ASLAN Pharmaceutical, Singapore
• Mark Goh
  Associate Professor, National University of Singapore, Director, The Logistics Institute – Asia Pacific, Singapore
• Maggie Gu
  Director, Clinical Development, AstraZeneca, China
• Ming Guo
  COO, Ascentage Pharma, China
• Yariv Hefez
  VP Business Development & Alliance Management, Biosimilars, Merck, Switzerland
• Amy Jiang
  Head of Quality, Sanofi Pasteur, China
• Suresh Kumar Kota
  Professor of Psychiatry, N.R.I. Medical College, India
• Pierre Letecheur
  Director, Servier Pharmaceutical Research & Development, China
• Jian Li
  Director, Partnering & External Innovation (Asia Pacific), Sanofi R&D, China
• Shell Li
  Head of Clinical Research, Executive Director, Boehringer Ingelheim, China
• Beverly Lui
  Director, Scientific Affairs, Amgen, China
• Mao Mao
  Research Fellow, Pfizer, USA
• Simon McErlane
  Senior Medical Director and Head of Clinical Services, Takeda Development Center Asia, Singapore
• Hua Mu
  Executive Vice President & Chief Medical Officer, Hutchison Medi Pharma
• Binhui Ni
  Head of Scouting & Partnering, Sanofi Aventis R&D, China
• Dan Paulson
  Global Clinical Leader, Cardiovascular Risk Management, Global Clinical Development, Bayer, China
• Khalid Saifuddin
  Head Central Continuous Remote Monitoring, Novartis, India
• Sylvie Sakata
  Senior Director, External Research Solutions West and Asia Region Lead, Pfizer, USA
• Cezary Statuch
  Vice President, Head of China R&D, Bristol-Myers Squibb, China
• Hiroshi Sugii
  Vice President, Novo Nordisk, Japan
• Yongkui Sun
  VP, Greater China Lead, External Scientific Affairs, Worldwide Licensing and Acquisitions, MSD R&D, China
• Dejun Tang
  Site Head, Biometrics & Statistical Sciences and Methodology. Novartis, China
• Andrew Taylor
  Head, Clinical Data Management, Asia-Pacific, Roche, China
• Vincenzo Teneggi
  Former Senior Director, Head, Early Development and Clinical Pharmacology R&D, GlaxoSmithKline, China
• Masakazu Toi
  Professor, Faculty of Medicine, Kyoto University, Japan
• James Tsui
  Scientific Sourcing, Contracts & Outsourcing, Roche, China
• Patrecia Valone
  Senior Director, Development Operations, Takeda Development Center Asia and Takeda Shanghai Development Center, Singapore
• Patrick Velicitat
  Regional Head Clinical Operations Japan, Boehringer Ingelheim, Japan
• Wei Wang
  Associate Director, Safety Surveillance and Risk Management, Pfizer, China
• Zaiqi Wang
  Head of Clinical Research, Merck, China
• Rebecca Wang
  Executive Medical Director, Bone Safety TA Head, Amgen, USA
• Anfan Wu
  Anfan Wu, Head, Early Development, Roche R&D, China
• Mingde Xia
  Senior Director, Johnson & Johnson, USA
• Toshinori Yamamoto
  Vice President and Head of Preclinical Research, RaQualia Pharma Inc., Japan
• Jin-San Yoo
  CEO and President of PharmAbcine, Inc. South Korea
• Jimmy Z. Zhang
  Managing Director, MSD Early Investments, Merck & Co., Inc., China
• Ming-Qiang Zhang
  Vice President & Head, Research and Development China, Amgen Inc, China
• Yumin Zhang
  Principal Research Scientist, Abbvie, USA
• Kezhou Zhang
  Vice President, Novo Nordisk, China
• Yi Zhun Zhu
  Professor, Dean of Pharmacology, Fudan University, China